Sri Lanka vs Trinidad and Tobago: Proportion of the target population who received the final dose of
Sri Lanka
12.0%
in 2024
Trinidad and Tobago
16.0%
in 2024
Sri Lanka rank
101st
Trinidad and Tobago rank
99th
Proportion of the target population who received the final dose of over time
- Sri Lanka
- Trinidad and Tobago
How they compare
Trinidad and Tobago currently reports 16.0% against 12.0% in Sri Lanka, a difference of 4.0%.
That makes Trinidad and Tobago's figure about 1.3 times Sri Lanka's.
The two have swapped places 1 time across 6 shared years of data; in 2018 it was Sri Lanka ahead.
Sri Lanka ranks 101st and Trinidad and Tobago ranks 99th of 107 countries.
Sri Lanka has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sri Lanka | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 68.5% | 10.5% | 58.0% | Sri Lanka |
| 2020s | 36.8% | 11.0% | 25.8% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Sri Lanka or Trinidad and Tobago?
- Trinidad and Tobago, at 16.0% against 12.0% in Sri Lanka as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Sri Lanka and Trinidad and Tobago?
- 4.0%, with Trinidad and Tobago ahead.
- How many years of comparable data are there for Sri Lanka and Trinidad and Tobago?
- 6 years are reported by both, from 2018 to 2024.
- How do Sri Lanka and Trinidad and Tobago rank globally for proportion of the target population who received the final dose of?
- Sri Lanka ranks 101st and Trinidad and Tobago ranks 99th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.